Skip to main content
Premium Trial:

Request an Annual Quote

Illumina to Provide Multi-Year Genotyping Services to GlaxoSmithKline

NEW YORK, Sept. 22 (GenomeWeb News) -- Illumina will provide further genotyping services for GlaxoSmithKline, the company said today.


Under the multi-year agreement, Illumina will use its Sentrix arrays as well as its GoldenGate and Infinium assays to analyze several thousand samples provided by GSK, which are part of several projects.


Illumina, which did not provide further details on the agreement, has already been providing genetic analyses for GSK since June 2001.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.